ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 691216 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 691216; 2) Community: the network communities that were significantly associated with the response to NSC 691216; 3) Molecule: the relationships between components within communities and NSC 691216; 4) MDR: the compounds that were significantly associated with the NSC 691216.

NSC Compound Enrichment Correlation
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0285477013888565 0.077934549
NSC 624657 ANTINEOPLASTIC-624657 0.0285477013888565 -0.10607735
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0285477013888565 -0.06329917
NSC 658257 Naphthalen-2-one, 4-[(4-bromophenyl)amino]-1,2-dihydro-1-(hydroxyimino)- 0.0285477013888565 -0.030391542
NSC 666126 Null 0.0285477013888565 0.034176536
NSC 670805 Null 0.0285477013888565 -0.074889691
NSC 673787 Null 0.0285477013888565 -0.091034445
NSC 677041 Null 0.0285477013888565 0.085822914
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0285477013888565 0.023435516
NSC 681632 Camptothecin Derivative 0.0285477013888565 0.0058850497
Total:45  Current:26    [First] [Prev] [Next] [Last]